Reports

Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.

Global Proton Pump Inhibitors (PPIs) Market: By Drug Type: OTC Drugs, Prescription Drugs; Regional Analysis; Historical Market and Forecast (2017-2027); Market Dynamics: SWOT Analysis, Porter’s Five Forces Analysis, EMR’s Key Indicators for Demand, EMR’s Key Indicators for Price; Competitive Landscape; Industry Events and Developments

Global Proton Pump Inhibitors (PPIs) Market Outlook

The global proton pump inhibitors (PPIs) market is expected to reach a value of USD 3.26 billion by 2026 over the forecast period of 2022-2027. The growth of the market is being driven by the reformulation of drugs with the exceptionality of patent extension that helps traders maintain their position in the market.

 

Global Proton Pump Inhibitors Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Market Segmentation

The proton pump inhibitors are a group of drugs that help in the reduction of gastric acid production. The proton pump inhibitors (PPIs) market can be broadly categorised based on drug type into:

 

Proton Pump Inhibitors (PPIs) Market By Drug Type

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

  • OTC Drugs
  • Omeprazole
  • Lansoprazole
  • Esomeprazole
  • Others
  • Prescription Drugs  
  • Rabeprazole
  • Dexlansoprazole
  • Pantoprazole
  • Others

The EMR report looks into the regional markets of proton pump inhibitors like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.

 

Proton Pump Inhibitors (PPIs) Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Market Analysis

The global proton pump inhibitors (PPIs) market is being driven by the increasing occurrence of gastroesophageal reflux disease and the rising recognition of novel drug delivery systems. The increasing shift from prescription to OTC drugs is driving the global proton pump inhibitors (PPIs) market growth. North America held the largest share in the industry as a result of the rising incidence of GERD and the increasing expenditure on promotion in countries like the U.S., Canada, and Mexico.

 

Competitive Landscape

The report presents a detailed analysis of the following key players in the global proton pump inhibitors (PPIs) market, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • AstraZeneca plc 
  • Bayer AG
  • Eli Lilly and Company
  • GlaxoSmithKline PLC
  • Eisai Co., Ltd.
  • Pfizer Inc.
  • Takeda Pharmaceutical Company Limited

The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s five forces.

 

REPORT FEATURES DETAILS
Base Year 2021
Historical Period 2017-2021
Forecast Period 2022-2027
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Drug Type, Region
Breakup by Drug Type OTC Drugs, Prescription Drugs
Breakup by Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Market Dynamics SWOT, Porter's Five Forces, Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered AstraZeneca plc, Bayer AG, Eli Lilly and Company, Eisai Co Ltd., GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Pfizer Inc..
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Proton Pump Inhibitors (PPIs) Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Proton Pump Inhibitors (PPIs) Historical Market (2017-2021) 
    8.3    Global Proton Pump Inhibitors (PPIs) Market Forecast (2022-2027)
    8.4    Global Proton Pump Inhibitors (PPIs) Market by Drug Type
        8.4.1    OTC Drugs
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2017-2021)
            8.4.1.3    Forecast Trend (2022-2027)
            8.4.1.1    Breakup by Type
                8.4.1.1.1    Omeprazole
                8.4.1.1.2    Lansoprazole
                8.4.1.1.3    Esomeprazole
                8.4.1.1.4    Others
        8.4.2    Prescription Drugs
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2017-2021)
            8.4.2.3    Forecast Trend (2022-2027)
            8.4.2.4    Breakup by Type
                8.4.2.4.1    Rabeprazole
                8.4.2.4.2    Dexlansoprazole
                8.4.2.4.3    Pantoprazole
                8.4.2.4.4    Others
    8.5    Global Proton Pump Inhibitors (PPIs) Market by Region
        8.5.1    Market Share
            8.5.1.1    North America
            8.5.1.2    Europe
            8.5.1.3    Asia Pacific
            8.5.1.4    Latin America
            8.5.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2017-2021)
        9.1.2    Forecast Trend (2022-2027)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2017-2021)
        9.2.2    Forecast Trend (2022-2027)
        9.2.3    Breakup by Country 
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2017-2021)
        9.3.2    Forecast Trend (2022-2027)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2017-2021)
        9.4.2    Forecast Trend (2022-2027)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2017-2021)
        9.5.2    Forecast Trend (2022-2027)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    Key Indicators for Demand
    10.4    Key Indicators for Price
11    Value Chain Analysis
12    Competitive Landscape

    12.1    Market Structure
    12.2    Company Profiles
        12.2.1    AstraZeneca PLC
            12.2.1.1    Company Overview
            12.2.1.2    Product Portfolio
            12.2.1.3    Demographic Reach and Achievements
            12.2.1.4    Certifications
        12.2.2    Bayer AG
            12.2.2.1    Company Overview
            12.2.2.2    Product Portfolio
            12.2.2.3    Demographic Reach and Achievements
            12.2.2.4    Certifications
        12.2.3    GlaxosmithKline plc
            12.2.3.1    Company Overview
            12.2.3.2    Product Portfolio
            12.2.3.3    Demographic Reach and Achievements
            12.2.3.4    Certifications
        12.2.4    Pfizer Inc.
            12.2.4.1    Company Overview
            12.2.4.2    Product Portfolio
            12.2.4.3    Demographic Reach and Achievements
            12.2.4.4    Certifications
        12.2.5    Eli Lilly and Company
            12.2.5.1    Company Overview
            12.2.5.2    Product Portfolio
            12.2.5.3    Demographic Reach and Achievements
            12.2.5.4    Certifications
        12.2.6    Eisai Co., Ltd.
            12.2.6.1    Company Overview
            12.2.6.2    Product Portfolio
            12.2.6.3    Demographic Reach and Achievements
            12.2.6.4    Certifications
        12.2.7    Takeda Pharmaceutical Company Limited
            12.2.7.1    Company Overview
            12.2.7.2    Product Portfolio
            12.2.7.3    Demographic Reach and Achievements
            12.2.7.4    Certifications
        12.2.8    Others
13    Industry Events and Developments


List of Key Figures and Tables

1.    Global Proton Pump Inhibitors (PPIs) Market: Key Industry Highlights, 2017 and 2027
2.    Global Proton Pump Inhibitors (PPIs) Historical Market: Breakup by Drug Type (USD Million), 2017-2021
3.    Global Proton Pump Inhibitors (PPIs) Market Forecast: Breakup by Drug Type (USD Million), 2022-2027
4.    Global Proton Pump Inhibitors (PPIs) Historical Market: Breakup by Region (USD Million), 2017-2021
5.    Global Proton Pump Inhibitors (PPIs) Market Forecast: Breakup by Region (USD Million), 2022-2027
6.    North America Proton Pump Inhibitors (PPIs) Historical Market: Breakup by Country (USD Million), 2017-2021
7.    North America Proton Pump Inhibitors (PPIs) Market Forecast: Breakup by Country (USD Million), 2022-2027
8.    Europe Proton Pump Inhibitors (PPIs) Historical Market: Breakup by Country (USD Million), 2017-2021
9.    Europe Proton Pump Inhibitors (PPIs) Market Forecast: Breakup by Country (USD Million), 2022-2027
10.    Asia Pacific Proton Pump Inhibitors (PPIs) Historical Market: Breakup by Country (USD Million), 2017-2021
11.    Asia Pacific Proton Pump Inhibitors (PPIs) Market Forecast: Breakup by Country (USD Million), 2022-2027
12.    Latin America Proton Pump Inhibitors (PPIs) Historical Market: Breakup by Country (USD Million), 2017-2021
13.    Latin America Proton Pump Inhibitors (PPIs) Market Forecast: Breakup by Country (USD Million), 2022-2027
14.    Middle East and Africa Proton Pump Inhibitors (PPIs) Historical Market: Breakup by Country (USD Million), 2017-2021
15.    Middle East and Africa Proton Pump Inhibitors (PPIs) Market Forecast: Breakup by Country (USD Million), 2022-2027
16.    Global Proton Pump Inhibitors (PPIs) Market Structure

Key Questions Answered in the Report

By 2026, the global proton pump inhibitors (PPIs) market is anticipated to attain a value of nearly USD 3.26 billion.

The major drivers of the market include the reformulation of drugs with the exceptionality of patent extension that helps traders maintain their position in the market.

Increasing occurrence of gastroesophageal reflux disease is the key industry trend propelling the growth of the market.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The major players in the industry are AstraZeneca plc, Bayer AG, Eli Lilly and Company, Eisai Co Ltd., GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Pfizer Inc..

Analyst Review

The global proton pump inhibitors (PPIs) market attained a value of USD 3.26 billion in 2026, driven by the reformulation of drugs with the exceptionality of patent extension that helps traders maintain their position in the market.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on drug type, the proton pump inhibitors (PPIs) industry can be segmented into OTC drugs, and prescription drugs. The major regional markets for proton pump inhibitors (PPIs) are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include AstraZeneca plc, Bayer AG, Eli Lilly and Company, Eisai Co Ltd., GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Pfizer Inc..

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports





NEWSLETTER